(19)
(11) EP 1 154 755 A1

(12)

(43) Date of publication:
21.11.2001 Bulletin 2001/47

(21) Application number: 00904531.1

(22) Date of filing: 24.01.2000
(51) International Patent Classification (IPC)7A61K 9/127
(86) International application number:
PCT/US0001/743
(87) International publication number:
WO 0042/990 (27.07.2000 Gazette 2000/30)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 25.01.1999 US 117094 P

(71) Applicants:
  • Optime Therapeutics, Inc.
    Petaluma, CA 94954-1158 (US)
  • Blue Ridge Pharmaceuticals, Inc.
    Greensboro, NC 27409-8112 (US)

(72) Inventors:
  • KINZELL, John
    San Rafael, CA 94903-3725 (US)
  • BAKER, Martin, T.
    Petaluma, CA 94954-1565 (US)
  • HEPLER, Douglas
    Mcleansville, NC 27301-9212 (US)

(74) Representative: Manitz, Finsterwald & Partner GbR 
Martin-Greif-Strasse 1
80336 München
80336 München (DE)

   


(54) LIPOSOME FORMULATIONS